Nanjing, China

Zhengbang Chen

This inventor holds 1 USPTO granted patent. Top assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhengbang Chen. Retrieved from https://idiyas.com/inventor/zhengbang-chen-ou24prr0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhengbang Chen: Innovator in Pharmaceutical Chemistry

Introduction

Zhengbang Chen is a notable inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on SOS1 inhibitors.

Latest Patents

Zhengbang Chen holds 1 patent related to an SOS1 inhibitor containing phosphorus. This patent pertains to a compound of formula (I) and outlines a preparation method for the compound. It also details a pharmaceutical composition that includes the compound and its application in developing drugs for treating diseases and disorders associated with SOS1.

Career Highlights

Zhengbang Chen is affiliated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where he continues to advance his research and development efforts in pharmaceutical innovations. His work is pivotal in addressing medical challenges related to SOS1.

Collaborations

Zhengbang Chen collaborates with esteemed colleagues, including Jinfa Hu and Baomin Liu, to further enhance the impact of their research in the pharmaceutical industry.

Conclusion

Zhengbang Chen's contributions to pharmaceutical chemistry, particularly through his work on SOS1 inhibitors, highlight his role as an influential inventor in the field. His ongoing research promises to lead to significant advancements in drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…